Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Evaluation of a Standardized Strategy for the Use of Bioresorbable Vascular Scaffold in ST-segment Elevation Myocardial Infarction: the BVS STEMI STRATEGY-IT Registry

NCT02601781 is registered in ClinicalTrials.gov with Azienda Ospedaliera Bolognini di Seriate Bergamo as lead sponsor.

NCT NCT02601781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02601781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Evaluation of a Standardized Strategy for the Use of Bioresorbable Vascular Scaffold in ST-segment Elevation Myocardial Infarction: the BVS STEMI STRATEGY-IT Registry
Lead sponsor
Azienda Ospedaliera Bolognini di Seriate Bergamo
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2015
Completion date
December 31, 2021
Enrollment
500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

st-elevation myocardial infarction (stemi)